New Program Launched ANN ARBOR, Mich. -- SensiGen LLC, a privately held biotechnology company focused on developing proprietary gene-based molecular diagnostic tests announced today a new program to make the Company's AttoSense[TM] HPV assay available to head and neck cancer researchers worldwide ...